News | May 11, 2022
Bayer posts higher sales, profit in first quarter
Company's net income rose by 57.5 percent to 3.291 billion euros in Q1
Company's net income rose by 57.5 percent to 3.291 billion euros in Q1
Omega plans to further strengthen its capabilities, deepen domain expertise and build new solutions
Pfizer to commercialize NURTEC ODT (rimegepant), an innovative compound for the prevention and acute treatment of migraine, a condition with high unmet need
Glenmark's current portfolio consists of 174 products authorized for distribution in the U.S. marketplace and 48 ANDA's pending approval with the USFDA
The FDA has determined that the known and potential benefits of the vaccine for the prevention of Covid-19 outweigh the known and potential risks for individuals 18 years of age and older for whom other authorized or approved vaccines are not accessible
While Pregabalin will be manufactured at the Aurangabad facility, Iloperidone will be manufactured at the Goa facility
The drug will be manufactured at the group's formulation facility at SEZ, Ahmedabad
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
The announcement follows FDA 510(k) clearance of device
Subscribe To Our Newsletter & Stay Updated
